<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>METAVIA RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sun, 17 May 2026 00:01:57 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/metavia%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>METAVIA RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Eff...</title><pubDate>Mon, 05 Jan 2026 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/metavia-reports-positive-statistically-significant-results-from-its-phase-1b-clinical-trial-of-da-1726-in-metabolic-disease-demonstrating-strong-glycemic-response-significant-direct-hepatic-eff-15392376</link><description><![CDATA[<p><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><i>Statistically Significant (p=0.006) Waist Circumference Reduction of 9.8 cm at Day 54</i><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><i>Significant Direct Hepatic Activity with a 23.7%  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/metavia-reports-positive-statistically-significant-results-from-its-phase-1b-clinical-trial-of-da-1726-in-metabolic-disease-demonstrating-strong-glycemic-response-significant-direct-hepatic-eff-15392376</guid></item><item><title>MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference</title><pubDate>Mon, 29 Dec 2025 14:31:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/metavia-to-participate-in-and-sponsor-the-10th-annual-mash-tag-2026-conference-15382795</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">CAMBRIDGE, Mass., <span class="legendSpanClass"><span class="xn-chron">Dec. 29, 2025 /PRNewswire/ -- <b>MetaVia Inc. </b>(Nasdaq: MTVA), a clinical-stage biotechnology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/metavia-to-participate-in-and-sponsor-the-10th-annual-mash-tag-2026-conference-15382795</guid></item><item><title>MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement</title><pubDate>Mon, 22 Dec 2025 14:31:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/metavia-regains-compliance-with-nasdaq-minimum-bid-price-requirement-15374503</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">CAMBRIDGE, Mass., <span class="legendSpanClass"><span class="xn-chron">Dec. 22, 2025 /PRNewswire/ -- <b>MetaVia Inc. </b>(Nasdaq: MTVA), a clinical-stage biotechnology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/metavia-regains-compliance-with-nasdaq-minimum-bid-price-requirement-15374503</guid></item><item><title>MetaVia Inc. Announces 1-for-11 Reverse Stock Split</title><pubDate>Tue, 02 Dec 2025 14:45:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/metavia-inc-announces-1-for-11-reverse-stock-split-15328222</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">CAMBRIDGE, Mass., <span class="legendSpanClass"><span class="xn-chron">Dec. 2, 2025 /PRNewswire/ -- <b>MetaVia Inc. </b>(Nasdaq: MTVA) ("<u>MetaVia</u>" or  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/metavia-inc-announces-1-for-11-reverse-stock-split-15328222</guid></item></channel></rss>
